David Werdegar

838 total citations · 1 hit paper
18 papers, 600 citations indexed

About

David Werdegar is a scholar working on Clinical Psychology, Epidemiology and General Health Professions. According to data from OpenAlex, David Werdegar has authored 18 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Clinical Psychology, 5 papers in Epidemiology and 4 papers in General Health Professions. Recurrent topics in David Werdegar's work include Substance Abuse Treatment and Outcomes (4 papers), Child and Adolescent Psychosocial and Emotional Development (4 papers) and Blood Pressure and Hypertension Studies (3 papers). David Werdegar is often cited by papers focused on Substance Abuse Treatment and Outcomes (4 papers), Child and Adolescent Psychosocial and Emotional Development (4 papers) and Blood Pressure and Hypertension Studies (3 papers). David Werdegar collaborates with scholars based in United States. David Werdegar's co-authors include Maurice Sokolow, James L. Sorensen, Joseph Guydish, John Mason, Dale G. Johnson, George W Rutherford, Sandra Schwarcz, J L Barnhart, Wayne M. Clark and Wayne Clark and has published in prestigious journals such as Circulation, Annals of Internal Medicine and Journal of Consulting and Clinical Psychology.

In The Last Decade

David Werdegar

16 papers receiving 539 citations

Hit Papers

Relationship Between Level of Blood Pressure Measured Cas... 1966 2026 1986 2006 1966 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Werdegar United States 8 330 115 112 55 53 18 600
David Walker United Kingdom 14 359 1.1× 104 0.9× 94 0.8× 41 0.7× 30 0.6× 27 674
Alessandra N. Faria Brazil 9 210 0.6× 65 0.6× 154 1.4× 51 0.9× 17 0.3× 12 645
Benjamin J. R. Buckley United Kingdom 16 325 1.0× 34 0.3× 98 0.9× 88 1.6× 42 0.8× 60 679
Valentina Bucciarelli Italy 16 398 1.2× 151 1.3× 83 0.7× 34 0.6× 9 0.2× 55 809
Monica M. DiNardo United States 16 196 0.6× 243 2.1× 294 2.6× 63 1.1× 11 0.2× 33 1.9k
Cecilia Bergh Sweden 11 157 0.5× 75 0.7× 107 1.0× 30 0.5× 8 0.2× 24 493
Betty Ho Australia 5 164 0.5× 55 0.5× 48 0.4× 96 1.7× 25 0.5× 7 395
Chia‐Hui Wang Taiwan 11 83 0.3× 102 0.9× 39 0.3× 58 1.1× 61 1.2× 31 428
Paula Aver Bretanha Ribeiro Canada 14 262 0.8× 56 0.5× 47 0.4× 36 0.7× 209 3.9× 47 879
Monica Siniscalchi Italy 14 120 0.4× 197 1.7× 287 2.6× 25 0.5× 9 0.2× 25 851

Countries citing papers authored by David Werdegar

Since Specialization
Citations

This map shows the geographic impact of David Werdegar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Werdegar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Werdegar more than expected).

Fields of papers citing papers by David Werdegar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Werdegar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Werdegar. The network helps show where David Werdegar may publish in the future.

Co-authorship network of co-authors of David Werdegar

This figure shows the co-authorship network connecting the top 25 collaborators of David Werdegar. A scholar is included among the top collaborators of David Werdegar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Werdegar. David Werdegar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Guydish, Joseph, et al.. (1999). A randomized trial comparing day and residential drug abuse treatment: 18-month outcomes.. Journal of Consulting and Clinical Psychology. 67(3). 428–434. 1 indexed citations
3.
Guydish, Joseph, et al.. (1999). A randomized trial comparing day and residential drug abuse treatment: 18-month outcomes.. Journal of Consulting and Clinical Psychology. 67(3). 428–434. 27 indexed citations
4.
Guydish, Joseph, et al.. (1998). Drug abuse day treatment: A randomized clinical trial comparing day and residential treatment programs.. Journal of Consulting and Clinical Psychology. 66(2). 280–289. 32 indexed citations
5.
Guydish, Joseph, et al.. (1998). Drug abuse day treatment: A randomized clinical trial comparing day and residential treatment programs.. Journal of Consulting and Clinical Psychology. 66(2). 280–289. 24 indexed citations
6.
Guydish, Joseph, et al.. (1997). Clients Entering Drug Abuse Day Treatment: 18-Month Outcomes. The American Journal of Drug and Alcohol Abuse. 23(1). 99–114. 2 indexed citations
7.
Marx, Rani, et al.. (1997). HIV education and prevention in California: problems and progress. HIV Education and Prevention Evaluation Team.. PubMed. 12(1). 31–45. 1 indexed citations
8.
Guydish, Joseph, et al.. (1995). A day treatment program in a therapeutic community setting: six-month Outcomes. Journal of Substance Abuse Treatment. 12(6). 441–447. 10 indexed citations
9.
Rutherford, George W, et al.. (1989). The Epidemiology of AIDS-Related Kaposi's Sarcoma in San Francisco. The Journal of Infectious Diseases. 159(3). 569–572. 58 indexed citations
10.
Werdegar, David, et al.. (1989). The epidemiology of acquired immunodeficiency syndrome.. PubMed. 44. 1–36. 7 indexed citations
11.
Werdegar, David, et al.. (1988). Impressions of health care and medical education in Japan.. PubMed. 17(4). 166–9. 3 indexed citations
12.
Rutherford, George W., et al.. (1988). Guidelines for the control of human immunodeficiency virus infection in adolescents.. PubMed. 148(5). 586–9. 1 indexed citations
13.
Werdegar, David. (1977). Guidelines for infection control aspects of employee health.. PubMed. 5(4). 15–22. 7 indexed citations
14.
Werdegar, David, et al.. (1968). Portable recordings of blood pressure: a new approach to assessments of the severity and prognosis of hypertension.. PubMed. 51. 93–115. 2 indexed citations
15.
Werdegar, David, et al.. (1968). Blood pressure responses to daily life events.. PubMed. 51. 116–29. 1 indexed citations
16.
Sokolow, Maurice, et al.. (1966). Relationship Between Level of Blood Pressure Measured Casually and by Portable Recorders and Severity of Complications in Essential Hypertension. Circulation. 34(2). 279–298. 388 indexed citations breakdown →
17.
Werdegar, David, Dale G. Johnson, & John Mason. (1964). A technique for continuous measurement of arterial blood pressure in unanesthetized monkeys. Journal of Applied Physiology. 19(3). 519–521. 26 indexed citations
18.
Werdegar, David, et al.. (1963). Enteric Protein Loss with Hypoproteinemia in Diffuse Lymphosarcoma of the Bowel. Annals of Internal Medicine. 59(2). 207–214. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026